Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 24, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Perspective Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 20
| |||||||
Perspective Therapeutics, Inc.
| 1.8K |
$9.82 | $17,667.00 | +5.27% | 35.97K |
Jun 17
| |||||||
Perspective Therapeutics, Inc.
| 25.01K |
$1.40 | $35,007.10 | +7.90% | 341.72K |
May 31
| |||||||
Perspective Therapeutics, Inc.
| 125K |
$0.26 | $32,337.50 | +65.20% | 316.71K |
Dec 18
| |||||||
Perspective Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Dec 12
| |||||||
Isoray, Inc.
| 85.4K |
$0.38 | $32,501.40 | +80.34% | 191.71K |
Dec 1 - Dec 5
| |||||||
Isoray, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 21
| |||||||
Isoray, Inc.
| 39K |
$0.29 | $11,160.86 | +57.94% | 106.31K |
Jun 7 - Jun 8
| |||||||
Isoray, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Isoray, Inc.
| 67.31K |
$0.52 | $34,999.12 |
∞
| 67.31K |
Oct 22
| |||||||
Isoray, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 23
| |||||||
Isoray, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 18
| |||||||
Isoray, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Perspective Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Perspective Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jul 1
| |||||||
Perspective Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Jun 1
| |||||||
Perspective Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 2
| |||||||
Perspective Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Oct 17
| |||||||
Perspective Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||